“Be Fearful When Others Are Greedy and Greedy When Others Are Fearful”
Warren Buffett
Recent TCBP News
- TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening • PR Newswire (US) • 10/03/2024 12:30:00 PM
- TCBP Announces Site Opening of Guys and St. Thomas Hospital • PR Newswire (US) • 09/25/2024 12:30:00 PM
- TCBP to Present at the 2024 ThinkEquity Conference in NYC • PR Newswire (US) • 09/24/2024 12:45:00 PM
- /C O R R E C T I O N -- TC BioPharm/ • PR Newswire (US) • 09/20/2024 08:00:00 PM
- TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial • PR Newswire (US) • 09/12/2024 12:30:00 PM
- TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox • PR Newswire (US) • 09/09/2024 12:30:00 PM
- TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox • PR Newswire (US) • 09/06/2024 08:00:00 PM
- TCBP Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference • PR Newswire (US) • 09/05/2024 12:30:00 PM
- TCBP Announces Dosing of 5 New Patients in ACHIEVE • PR Newswire (US) • 09/03/2024 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/30/2024 07:52:09 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 08/29/2024 09:11:40 PM
- Form F-1MEF - Registration statement to add securities to prior Form F-1 registration [Rule 462(b)] • Edgar (US Regulatory) • 08/28/2024 10:32:48 PM
- TC BioPharm Announces Closing of Upsized $6.0 Million Public Offering • PR Newswire (US) • 08/28/2024 09:15:00 PM
- TC BioPharm Announces Grant of European Patent Covering Use of Modified Gamma Delta Cells for the Treatment of Cancer and Viral Indications • PR Newswire (US) • 08/28/2024 05:50:00 PM
- Form F-1/A - Registration statement for certain foreign private issuers: [Amend] • Edgar (US Regulatory) • 08/23/2024 09:30:30 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/23/2024 08:05:25 PM
- Form F-1 - Registration statement for certain foreign private issuers • Edgar (US Regulatory) • 08/16/2024 08:20:27 PM
- TC BioPharm Regains Compliance with Nasdaq Listing Rule 5550(b) • PR Newswire (US) • 08/15/2024 05:00:00 PM
- TC BioPharm Announces Closing of $2.0 Million Public Offering • PR Newswire (US) • 08/15/2024 03:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/15/2024 02:47:52 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 08/14/2024 11:30:44 AM
- TC BioPharm Announces Pricing of $2.0 Registered Direct Offering • PR Newswire (US) • 08/13/2024 08:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/13/2024 04:15:07 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/08/2024 08:30:07 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/06/2024 08:05:10 PM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • Oct 15, 2024 8:21 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM
One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM
CBD Life Sciences, Inc. Announces Strategic MOU with U.S. Armed Forces for Groundbreaking Mushroom Supplement • CBDL • Oct 15, 2024 8:00 AM
HealthLynked Files Non-Provisional Patent for AI-Powered Healthcare Assistant, ARi • HLYK • Oct 15, 2024 8:00 AM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM